OSIRIS THERAPEUTICS,INC. (NASDAQ:OSIR) Files An 8-K Other EventsItem 8.01. Other Events.
Any stockholder of the Company who wishes to submit a proposal for inclusion in the Company’s proxy statement for the 2018 Annual Meeting must comply with the requirements of Rule14a-8 under the Securities and Exchange Act of 1934 and deliver such proposal to the Company no later than April30, 2018. Submissions should be addressed to Corporate Secretary, Osiris Therapeutics,Inc., at 7015 Albert Einstein Drive, Columbia, Maryland 21046.